GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Levitee Labs Inc (XCNQ:LVT) » Definitions » Shares Outstanding (EOP)

Levitee Labs (XCNQ:LVT) Shares Outstanding (EOP) : 75.82 Mil (As of Jun. 2022)


View and export this data going back to 2021. Start your Free Trial

What is Levitee Labs Shares Outstanding (EOP)?

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. Levitee Labs's shares outstanding for the quarter that ended in Jun. 2022 was 75.82 Mil.

Levitee Labs's quarterly shares outstanding increased from Mar. 2022 (70.37 Mil) to Jun. 2022 (75.82 Mil). It means Levitee Labs issued new shares from Mar. 2022 to Jun. 2022 .

Levitee Labs's annual shares outstanding declined from Sep. 2020 (80.11 Mil) to Sep. 2021 (61.43 Mil). It means Levitee Labs bought back shares from Sep. 2020 to Sep. 2021 .


Levitee Labs Shares Outstanding (EOP) Historical Data

The historical data trend for Levitee Labs's Shares Outstanding (EOP) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Levitee Labs Shares Outstanding (EOP) Chart

Levitee Labs Annual Data
Trend Sep20 Sep21
Shares Outstanding (EOP)
80.11 61.43

Levitee Labs Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22
Shares Outstanding (EOP) Get a 7-Day Free Trial Premium Member Only 80.11 61.43 62.20 70.37 75.82

Competitive Comparison of Levitee Labs's Shares Outstanding (EOP)

For the Drug Manufacturers - Specialty & Generic subindustry, Levitee Labs's Shares Outstanding (EOP), along with its competitors' market caps and Shares Outstanding (EOP) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Levitee Labs's Shares Outstanding (EOP) Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Levitee Labs's Shares Outstanding (EOP) distribution charts can be found below:

* The bar in red indicates where Levitee Labs's Shares Outstanding (EOP) falls into.



Levitee Labs Shares Outstanding (EOP) Calculation

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. They have voting rights and represent ownership in the corporation by the person that holds the shares. They should be distinguished from treasury shares, which are shares held by the corporation itself, having no exercisable rights.

Shares outstanding can be calculated as either basic or fully diluted. The fully diluted shares outstanding count includes diluting securities, such as options, warrants or convertibles.

Please note: GuruFocus named Shares Outstanding (EOP) is the shares for that end of period. It is usually used to calculate balance sheet related items, such as Book Value per Share, etc. While Shares Outstanding (Diluted Average) and Shares Outstanding (Basic Average) are the weighted average shares over a period of time (a year, a quarter, or so). They are usually used to calculate income statement or cashflow statement related items, such as Earnings per Share (Diluted), etc.


Levitee Labs  (XCNQ:LVT) Shares Outstanding (EOP) Explanation

A company may buy back shares or issue shares in any fiscal period. If a company buys back shares, we should observe that the total number of shares decline. If the company issues new shares, the number of shares outstanding increases.

Usually the presence of treasury shares and a history of buyback are good indicators that company has competitive advantage. But studies have shown that companies usually buy back at wrong time. Buying back shares below its intrinsic value increases value for remaining shareholders. Buying back overvalued shares destroys value for existing shareholders.


Be Aware

Warren Buffett looks for consistency and upward long term trend. Because of share repurchase it is possible for net earnings trend to differ from EPS trend. He preferred net income over EPS. The companies with durable competitive advantage companies report higher % net earnings to total revenues.

Important: If a company is showing net earnings history greater than 20% on total revenues, it is probably benefiting from a long term competitive advantage.

If net earnings is less than 10%, likely to be in a highly competitive business.


Levitee Labs Shares Outstanding (EOP) Related Terms

Thank you for viewing the detailed overview of Levitee Labs's Shares Outstanding (EOP) provided by GuruFocus.com. Please click on the following links to see related term pages.


Levitee Labs (XCNQ:LVT) Business Description

Traded in Other Exchanges
N/A
Address
800 West Pender Street, Suite 215, Vancouver, CAN, V6C 2V6
Levitee Labs Inc is a functional mushrooms company, focused on the development and sale of high potency mushroom extract nutraceuticals and supplies and equipment for mushroom cultivation. The company believes, based on a growing body of research, that mushrooms can be an effective way to enhance wellbeing and potentially treat various kinds of mental and physical health problems. The medical services segment is engaged in providing medical treatment. The selling products segment is into buying and selling products Substantial revenue is generated from medical services operations.

Levitee Labs (XCNQ:LVT) Headlines

No Headlines